Please assess the completion status of the following clinical trial:

Trial Title: The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients tested negative for pregnancy and agreed to use appropriate contraceptives through out the study~* Patient was a nonsmoker~* Patient was in good general health (except for asthma)~Exclusion Criteria:~* Patient was hospitalized~* Patient was female who was less than 8 weeks postpartum or breast feeding~* Patient planned to move or vacation away during the study~* Patient had major surgery within 4 weeks the past 4 weeks~* Patient has donated blood or participated in a clinical trial within the past 4 weeks~* Patient was a regular user or recent abuser of alcohol or illicit drugs~* Patient was 40% over or under normal weight for height

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Montelukast + Beclomethasone
- 2 (Type: EXPERIMENTAL): Montelukast + Placebo inhaler
- 3 (Type: EXPERIMENTAL): Placebo tablet + Beclomethasone
- 4 (Type: PLACEBO_COMPARATOR): Placebo tablet + Placebo inhaler

Based on this trial design, predict the completion outcome and termination type (if applicable).